ID: ALA2393327

Max Phase: Preclinical

Molecular Formula: C9H9N3

Molecular Weight: 159.19

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Nc1ccc2c(N)ccnc2c1

Standard InChI:  InChI=1S/C9H9N3/c10-6-1-2-7-8(11)3-4-12-9(7)5-6/h1-5H,10H2,(H2,11,12)

Standard InChI Key:  TWLGPWZTMALXOR-UHFFFAOYSA-N

Associated Targets(non-human)

Ferriprotoporphyrin IX 165 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 159.19Molecular Weight (Monoisotopic): 159.0796AlogP: 1.40#Rotatable Bonds: 0
Polar Surface Area: 64.93Molecular Species: BASEHBA: 3HBD: 2
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.54CX LogP: 0.47CX LogD: -0.81
Aromatic Rings: 2Heavy Atoms: 12QED Weighted: 0.57Np Likeness Score: -0.39

References

1. Nsumiwa S, Kuter D, Wittlin S, Chibale K, Egan TJ..  (2013)  Structure-activity relationships for ferriprotoporphyrin IX association and β-hematin inhibition by 4-aminoquinolines using experimental and ab initio methods.,  21  (13): [PMID:23669191] [10.1016/j.bmc.2013.04.040]

Source